INTERNATIONAL PATENT: TUNE THERAPEUTICS, INC. FILES APPLICATION FOR "DNA METHYLTRANSFERASE-LIKE PROTEIN (DNMT3L) OR DNA METHYLTRANSFERASE 3A (DNMT3A) REPRESSOR SYSTEMS FOR EPIGENETIC EDITING"

GENEVA, March 31 -- TUNE THERAPEUTICS, INC. (1930 Boren Avenue, Floor 5Seattle, Washington 98101) filed a patent application (PCT/US2025/047433) for "DNA METHYLTRANSFERASE-LIKE PROTEIN (DNMT3L) OR DNA METHYLTRANSFERASE 3A (DNMT3A) REPRESSOR SYSTEMS FOR EPIGENETIC EDITING" on Sep 22, 2025. With publication no. WO/2026/064753, the details related to the patent application was published on Mar 26, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): GOUGH, Veronica (c/o Tune Therapeutics, Inc.300 Morris St., Suite 320Durham, North Carolina 27701), CHELLAPPAN, Malathi (c/o Tune Therapeutics, Inc.300 ...